Finland· FI-REL-REL50592
Droglican
A other specific antirheumatic agents product containing chondroitin sulfate sodium + glucosamine hydrochloride, registered in Finland by Laboratorio Reig Jofré, S.A.. The same ATC class is registered in 3 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Chondroitin sulfate sodium + glucosamine hydrochloride is registered in 3 of 19 countries.
Countries holding a registration under ATC M01CX (other specific antirheumatic agents), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Chondroitin sulfate sodium + glucosamine hydrochloride · ATC M01CX
3 / 19 countries
- Finlandprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Chondroitin sulfate sodium + Glucosamine hydrochloride
- Manufacturer
- Laboratorio Reig Jofré, S.A.
- Country
- Finland (FI)
- ATC code
- M01CX
- ATC class
- Other specific antirheumatic agents
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chondroitin sulfate sodium + glucosamine hydrochloride in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBio-Glucosamine MEGA tabletsPharma Nord (UK) Ltd
- PolandChronadaLaboratorio Reig Jofré S.A.
- SpainDROGLICAN 200 mg/250 mg CAPSULAS DURASLaboratorio Reig Jofre, S.A.
- FranceCARTIFIT 200 mg/250 mg, géluleLABORATORIO REIG JOFRE (ESPAGNE)
- NorwayGlucosamine HCl + Chondroitin pure encapPure encapsulations
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Austria · Cartifit
- Spain · Droglican
- France · Cartifit
- Hungary · Droglycan
- Poland · Chronada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/01c40249-9396-48a9-ad10-1fa166a470ce GET /v1/drugs/01c40249-9396-48a9-ad10-1fa166a470ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "kapseli, kova",
"route": "Suun kautta",
"ddd_unit": null,
"strength": "200 mg / 250 mg",
"atc_label": "Muut spesifiset reumalääkkeet",
"ma_number": "34954",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL50592",
"authorised_at": "2017-11-20"
}See everything about chondroitin sulfate sodium + glucosamine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.